Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

Characteristics of successful changes in health care organizations: an interview study with physicians, registered nurses and assistant nurses.

Nilsen P, Seing I, Ericsson C, Birken SA, Schildmeijer K.

BMC Health Serv Res. 2020 Feb 27;20(1):147. doi: 10.1186/s12913-020-4999-8.

2.

Visible-Light-Enabled Aminocarbonylation of Unactivated Alkyl Iodides with Stoichiometric Carbon Monoxide for Application on Late-Stage Carbon Isotope Labeling.

Sardana M, Bergman J, Ericsson C, Kingston LP, Schou M, Dugave C, Audisio D, Elmore CS.

J Org Chem. 2019 Dec 20;84(24):16076-16085. doi: 10.1021/acs.joc.9b02575. Epub 2019 Dec 11.

3.

Pasteurella multocida vertebral osteomyelitis, myositis and epidural abscess in a diabetic cirrhotic patient.

Malek AE, Fares JE, Raad II, Ericsson C.

IDCases. 2019 Aug 24;18:e00630. doi: 10.1016/j.idcr.2019.e00630. eCollection 2019.

4.

Implementation of change in health care in Sweden: a qualitative study of professionals' change responses.

Nilsen P, Schildmeijer K, Ericsson C, Seing I, Birken S.

Implement Sci. 2019 May 14;14(1):51. doi: 10.1186/s13012-019-0902-6.

5.

Can patients contribute to safer care in meetings with healthcare professionals? A cross-sectional survey of patient perceptions and beliefs.

Ericsson C, Skagerström J, Schildmeijer K, Årestedt K, Broström A, Pakpour A, Nilsen P.

BMJ Qual Saf. 2019 Aug;28(8):657-666. doi: 10.1136/bmjqs-2018-008524. Epub 2019 Apr 24.

6.

When should travel medicine practitioners prescribe Rifamycin SV-MXX for self-treatment of travellers' diarrhoea?

Ericsson CD, Connor BA, Riddle MS.

J Travel Med. 2019 May 10;26(3). pii: taz013. doi: 10.1093/jtm/taz013. No abstract available.

PMID:
30848819
7.

Determinants of patient participation for safer care: A qualitative study of physicians' experiences and perceptions.

Schildmeijer K, Nilsen P, Ericsson C, Broström A, Skagerström J.

Health Sci Rep. 2018 Sep 12;1(10):e87. doi: 10.1002/hsr2.87. eCollection 2018 Oct.

8.

Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin.

Samannodi M, Villavicencio A, Zhao A, Chavez V, Ericsson CD.

IDCases. 2018 Nov 3;14:e00465. doi: 10.1016/j.idcr.2018.e00465. eCollection 2018.

9.

Stand-by antibiotics for travellers' diarrhoea: risks, benefits and research needs.

Riddle MS, Ericsson CD, Gutierrez RL, Porter CK.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay099. No abstract available.

PMID:
30312427
10.

Should travel medicine practitioners prescribe antibiotics for self-treatment of travelers' diarrhea?

Ericsson CD, Riddle MS.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay081. No abstract available.

PMID:
30184202
11.

Uptake and tissue accretion of orally administered free carboxylic acid as compared to ethyl ester form of docosahexaenoic acid (DHA) in the rat.

Lindblom A, Ericsson C, Hagstedt T, Kjellstedt A, Oscarsson J, Oakes ND.

PLoS One. 2018 Aug 2;13(8):e0201367. doi: 10.1371/journal.pone.0201367. eCollection 2018.

12.

Screening Circulating Tumor Cells as a Noninvasive Cancer Test in 3388 Individuals from High-Risk Groups (ICELLATE2).

Castro J, Sanchez L, Nuñez MT, Lu M, Castro T, Sharifi HR, Ericsson C.

Dis Markers. 2018 May 28;2018:4653109. doi: 10.1155/2018/4653109. eCollection 2018.

13.

Reply to 'Travellers' diarrhoea in children: a blind spot in the expert panel guidelines on prevention and treatment'.

Riddle MS, Connor BA, Steffen R, Kozarsky P, Ericsson CD.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tax095. No abstract available.

PMID:
29788399
14.

Så ville patienter förbättra vårdmötet för att få säkrare vård.

Schildmeijer K, Skagerström J, Ericsson C, Nilsen P.

Lakartidningen. 2018 Feb 23;115. pii: EXIL. Swedish.

15.

Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations.

Altshuler J, Guervil DJ, Ericsson CD, Wanger A, Aitken SL, Ostrosky-Zeichner L.

J Pharm Pract. 2018 Feb;31(1):34-39. doi: 10.1177/0897190017696950. Epub 2017 Mar 6.

PMID:
29278990
16.

Reply to JTM-17-106 Comment on 'Guidelines for the prevention of and treatment of travellers' diarrhoea: a graded expert panel report by Riddle et al.'

Riddle MS, Connor BA, Burgess T, Ericsson CD.

J Travel Med. 2017 Sep 1;24(6). doi: 10.1093/jtm/tax060. No abstract available.

PMID:
29088482
17.

Patient involvement for improved patient safety: A qualitative study of nurses' perceptions and experiences.

Skagerström J, Ericsson C, Nilsen P, Ekstedt M, Schildmeijer K.

Nurs Open. 2017 Aug 29;4(4):230-239. doi: 10.1002/nop2.89. eCollection 2017 Oct.

18.

[Patient involvement from rhetoric to practice].

Nilsen P, Ericsson C, Skagerström J, Schildmeijer K.

Lakartidningen. 2017 Jun 28;114. pii: EPWP. Swedish. No abstract available.

19.

Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report.

Riddle MS, Connor BA, Beeching NJ, DuPont HL, Hamer DH, Kozarsky P, Libman M, Steffen R, Taylor D, Tribble DR, Vila J, Zanger P, Ericsson CD.

J Travel Med. 2017 Apr 1;24(suppl_1):S57-S74. doi: 10.1093/jtm/tax026. Review.

20.

Prevention and treatment of travellers' diarrhea.

Ericsson CD.

J Travel Med. 2017 Apr 1;24(suppl_1):S1. doi: 10.1093/jtm/tax018. No abstract available.

PMID:
28521003
21.

Toward molecular imaging of the free fatty acid receptor 1.

Hellström-Lindahl E, Åberg O, Ericsson C, O'Mahony G, Johnström P, Skrtic S, Eriksson O.

Acta Diabetol. 2017 Jul;54(7):663-668. doi: 10.1007/s00592-017-0989-7. Epub 2017 Apr 13.

22.

[Patient participation for safer health care – interviews with physicians and nurses].

Nilsen P, Skagerström J, Ericsson C, Schildmeijer K.

Lakartidningen. 2017 Mar 24;114. pii: EDWP. Swedish.

23.

Synthesis of 2 C-14 labeled cathepsin C inhibitors: The use of a cyanide to displace a Benzotriazole.

Kingston L, Bergare J, Lönn H, Ericsson C, Grönberg G, Chen S, Elmore CS.

J Labelled Comp Radiopharm. 2017 May 30;60(6):294-301. doi: 10.1002/jlcr.3502.

PMID:
28324911
24.

The synthesis of a tritium, carbon-14, and stable isotope-labeled cathepsin C inhibitors.

Allen P, Bragg RA, Caffrey M, Ericsson C, Hickey MJ, Kingston LP, Elmore CS.

J Labelled Comp Radiopharm. 2017 Feb;60(2):124-129. doi: 10.1002/jlcr.3483. Epub 2016 Dec 21.

PMID:
27868229
25.

Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center.

Torres HA, Roach LR, Mahale P, Economides MP, Blechacz B, Miller E, Borchardt R, Rashid A, Oo TH, Shukla B, Farida M, Ericsson CD, Granwehr BP, Raad II.

J Natl Compr Canc Netw. 2016 Sep;14(9):1185-8. No abstract available.

PMID:
27587628
26.

The synthesis of tritium, carbon-14 and stable isotope labelled selective estrogen receptor degraders.

Bragg RA, Bushby N, Ericsson C, Kingston LP, Ji H, Elmore CS.

J Labelled Comp Radiopharm. 2016 Sep;59(11):454-61. doi: 10.1002/jlcr.3437. Epub 2016 Aug 24.

PMID:
27558079
27.

Synthesis of [(3) H] and [(2) H6 ]AZD6642, an inhibitor of 5-lipoxygenase activating protein (FLAP).

Lindelöf Å, Ericsson C, Simonsson R, Nilsson G, Grönberg G, Elmore CS.

J Labelled Comp Radiopharm. 2016 Jul;59(9):340-5. doi: 10.1002/jlcr.3409. Epub 2016 Jun 14.

PMID:
27298225
28.

Abstracts of the 24th international isotope society (UK group) symposium: synthesis and applications of labelled compounds 2015.

Aigbirhio FI, Allwein S, Anwar A, Atzrodt J, Audisio D, Badman G, Bakale R, Berthon F, Bragg R, Brindle KM, Bushby N, Campos S, Cant AA, Chan MY, Colbon P, Cornelissen B, Czarny B, Derdau V, Dive V, Dunscombe M, Eggleston I, Ellis-Sawyer K, Elmore CS, Engstrom P, Ericsson C, Fairlamb IJ, Georgin D, Godfrey SP, He L, Hickey MJ, Huscroft IT, Kerr WJ, Lashford A, Lenz E, Lewinton S, L'Hermite MM, Lindelöf Å, Little G, Lockley WJ, Loreau O, Maddocks S, Marguerit M, Mirabello V, Mudd RJ, Nilsson GN, Owens PK, Pascu SI, Patriarche G, Pimlott SL, Pinault M, Plastow G, Racys DT, Reif J, Rossi J, Ruan J, Sarpaki S, Sephton SM, Simonsson R, Speed DJ, Sumal K, Sutherland A, Taran F, Thuleau A, Wang Y, Waring M, Watters WH, Wu J, Xiao J.

J Labelled Comp Radiopharm. 2016 Apr;59(4):175-86. doi: 10.1002/jlcr.3377. Epub 2016 Mar 18.

PMID:
26991121
29.

High Rate of Implementation of Proposed Actions for Improvement With the Healthcare Failure Mode Effect Analysis Method: Evaluation of 117 Analyses.

Öhrn A, Ericsson C, Andersson C, Elfström J.

J Patient Saf. 2018 Mar;14(1):17-20. doi: 10.1097/PTS.0000000000000159.

PMID:
25719818
30.

Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia.

Aitken SL, Altshuler J, Guervil DJ, Hirsch EB, Ostrosky-Zeichner LL, Ericsson CD, Tam VH.

Int J Antimicrob Agents. 2015 May;45(5):541-4. doi: 10.1016/j.ijantimicag.2014.12.018. Epub 2015 Jan 19.

PMID:
25665726
31.

Prostate biopsy sampling causes hematogenous dissemination of epithelial cellular material.

Ladjevardi S, Auer G, Castro J, Ericsson C, Zetterberg A, Häggman M, Wiksell H, Jorulf H.

Dis Markers. 2014;2014:707529. doi: 10.1155/2014/707529. Epub 2014 Jan 28.

32.

Synthesis of ximelagatran, melagatran, hydroxymelagatran, and ethylmelagatran in H-3 labeled form.

Simonsson R, Stenhagen G, Ericsson C, Elmore CS.

J Labelled Comp Radiopharm. 2013 May 30;56(6):334-7. doi: 10.1002/jlcr.3028. Epub 2013 Feb 16.

PMID:
24285415
33.

EpCAM associates with endoplasmic reticulum aminopeptidase 2 (ERAP2) in breast cancer cells.

Gadalla SE, Öjemalm K, Vasquez PL, Nilsson I, Ericsson C, Zhao J, Nistér M.

Biochem Biophys Res Commun. 2013 Sep 20;439(2):203-8. doi: 10.1016/j.bbrc.2013.08.059. Epub 2013 Aug 26.

PMID:
23988446
34.

[Risk of prolactinoma growth during pregnancy. Visual field tests required in macroadenoma, small risk in microadenomas].

Ericsson C, Lindblom B.

Lakartidningen. 2012 Jun 19-26;109(25):1226-8. Swedish. No abstract available.

PMID:
22838112
35.

Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease.

Silveira A, Scanavini D, Boquist S, Ericsson CG, Hellénius ML, Leander K, de Faire U, Ohrvik J, Woodhams B, Morrissey JH, Hamsten A.

Thromb Res. 2012 Aug;130(2):221-5. doi: 10.1016/j.thromres.2011.08.029. Epub 2011 Sep 16.

36.

Vibrio parahemolyticus septicaemia in a liver transplant patient: a case report.

Fernando RR, Krishnan S, Fairweather MG, Ericsson CD.

J Med Case Rep. 2011 May 6;5:171. doi: 10.1186/1752-1947-5-171.

37.

Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma.

Holmberg J, He X, Peredo I, Orrego A, Hesselager G, Ericsson C, Hovatta O, Oba-Shinjo SM, Marie SK, Nistér M, Muhr J.

PLoS One. 2011 Mar 31;6(3):e18454. doi: 10.1371/journal.pone.0018454.

38.

Uncoupling of the ERα regulated morphological phenotype from the cancer stem cell phenotype in human breast cancer cell lines.

Gadalla SE, Alexandraki A, Lindström MS, Nistér M, Ericsson C.

Biochem Biophys Res Commun. 2011 Feb 25;405(4):581-7. doi: 10.1016/j.bbrc.2011.01.072. Epub 2011 Jan 23.

PMID:
21266162
39.

Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study.

Bennermo M, Nordin M, Lundman P, Boqvist S, Held C, Samnegård A, Ericsson CG, Silveira A, Hamsten A, Nastase MM, Tornvall P.

J Interferon Cytokine Res. 2011 Feb;31(2):259-64. doi: 10.1089/jir.2010.0036. Epub 2010 Nov 17.

PMID:
21087078
40.

Blood plasma handling for protein analysis.

Ericsson C, Nistér M.

Methods Mol Biol. 2011;675:333-41. doi: 10.1007/978-1-59745-423-0_20.

PMID:
20949401
41.

Handling of solid brain tumor tissue for protein analysis.

Ericsson C, Nistér M.

Methods Mol Biol. 2011;675:327-32. doi: 10.1007/978-1-59745-423-0_19.

PMID:
20949400
42.

Protein extraction from solid tissue.

Ericsson C, Nistér M.

Methods Mol Biol. 2011;675:307-12. doi: 10.1007/978-1-59745-423-0_17.

PMID:
20949398
43.

Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico.

Martinez-Sandoval F, Ericsson CD, Jiang ZD, Okhuysen PC, Romero JH, Hernandez N, Forbes WP, Shaw A, Bortey E, DuPont HL.

J Travel Med. 2010 Mar-Apr;17(2):111-7. doi: 10.1111/j.1708-8305.2009.00385.x.

44.

Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico.

Koo HL, Ajami NJ, Jiang ZD, Neill FH, Atmar RL, Ericsson CD, Okhuysen PC, Taylor DN, Bourgeois AL, Steffen R, DuPont HL.

J Clin Microbiol. 2010 May;48(5):1673-6. doi: 10.1128/JCM.02072-09. Epub 2010 Mar 19.

45.

Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma.

Yin S, Girnita A, Strömberg T, Khan Z, Andersson S, Zheng H, Ericsson C, Axelson M, Nistér M, Larsson O, Ekström TJ, Girnita L.

Neuro Oncol. 2010 Jan;12(1):19-27. doi: 10.1093/neuonc/nop008. Epub 2009 Oct 20.

46.

B-Alkylcatecholborane-mediated tandem radical conjugated addition-aldol cyclization.

Beauseigneur A, Ericsson C, Renaud P, Schenk K.

Org Lett. 2009 Aug 20;11(16):3778-81. doi: 10.1021/ol9014943.

PMID:
19630429
47.

Travelers' preferences for the treatment and prevention of acute diarrhea.

Ericsson CD, Melgarejo NA, Jelinek T, McCarthy A; International Society of Travel Medicine Clinical Research Group.

J Travel Med. 2009 May-Jun;16(3):172-8. doi: 10.1111/j.1708-8305.2009.00317.x. Epub 2009 May 5. Erratum in: J Travel Med. 2010 May-Jun;17(3):181.

48.

Expert review of the evidence base for self-therapy of travelers' diarrhea.

DuPont HL, Ericsson CD, Farthing MJ, Gorbach S, Pickering LK, Rombo L, Steffen R, Weinke T.

J Travel Med. 2009 May-Jun;16(3):161-71. doi: 10.1111/j.1708-8305.2009.00300.x. Epub 2009 Mar 19. Review. No abstract available.

49.

Expert review of the evidence base for prevention of travelers' diarrhea.

DuPont HL, Ericsson CD, Farthing MJ, Gorbach S, Pickering LK, Rombo L, Steffen R, Weinke T.

J Travel Med. 2009 May-Jun;16(3):149-60. doi: 10.1111/j.1708-8305.2008.00299.x. Epub 2009 Mar 19. Review.

50.

Oxygen-depleted surfaces: a new antifouling technology.

Lindgren JF, Haeffner M, Ericsson CT, Jonsson PR.

Biofouling. 2009;25(5):455-61. doi: 10.1080/08927010902903204.

PMID:
19353389

Supplemental Content

Loading ...
Support Center